As promised, we bring you the new and improved FiercePharma

laptop against white background

Many of you saw the new FierceBiotech website launch earlier this week and now I am pleased to bring you the newly redesigned FiercePharma.  Our new website brings all of your Pharma news to a central hub through a more reader-friendly experience.   

Now you can find all of our Pharma related content including stories from our sister sites FiercePharmaManufacturing, FiercePharmaMarketing, FiercePharmaAsia, FierceAnimalHealth, FierceDrugDelivery, and FierceVaccines on one site: You will still receive your regular newsletters, so if you subscribe to one of our sister publications the only change you’ll see is a more slimmed-down format.

What’s more exciting than what you’ll see at kickoff are the new features that will enhance our reporting – from social integrations to data visualizations – in the days and weeks to come.   

You’ll also be able to enjoy our content more fully when you're on the go, because our sites will be viewable on desktop, mobile and tablet devices. 

We’re excited to debut the new capabilities the redesign allows and we hope you enjoy our new look. Take a spin through the sites and let me know what you think. 

As always, thank you for reading and for being a part of the FiercePharma community.  – Rebecca Willumson (email | Twitter)

Suggested Articles

Esperion's Nexletol has had a rough road to approval after safety concerns nearly derailed its quest. But an FDA nod has the drug ready for market.

In an interview with Israel's Calcalist, Teva CEO Kåre Schultz shared details of his approach to the company's turnaround.

Nerlynx is already struggling in its extended adjuvant breast cancer setting, and new entrants from Daiichi-AZ and SeaGen could pressure it elsewhere.